Resources

alternative to biologic medicines
July 23, 2020
Biologic medicines involve complex research and development. They are often expensive. Patients have an alternative to biologic medicines: biosimilars.
biosimilars benefit everyone
July 22, 2020
Biosimilars are FDA-approved alternatives to reference biologics – much like generic drugs – that provide treatment options for patients who need biologic medicines to manage their conditions.
biosimilars in the pharmacy
July 16, 2020
Biosimilars in the pharmacy benefit employers driving appropriate use and transparency.
europe's biosimilars market
June 3, 2020
This paper delves into the lessons the United States should adopt to speed the development of its market while also highlighting European market pitfalls to avoid.
Approved Biosimilars
April 23, 2020
Find an up-to-date list of FDA approved biosimilars and launches.
Bulletin March
April 7, 2020
March's newsletter with the latest updates in the biosimilars industry including policy movement, educational resources and upcoming events.

Recent Tweets

If the entire Affordable Care Act (#ACA) is overturned as unconstitutional, it could eliminate the Biologics Price Competition and Innovation Act (#BPCIA) and threaten the accessibility of life-saving treatments in the U.S.

Read more: https://www.washingtonpost.com/opinions/letters-to-the-editor/striking-down-obamacare-would-also-nix-generic-biologic-drugs/2020/06/28/44a4a630-b7c4-11ea-9a1d-d3db1cbe07ce_story.html

Load More...

Want to keep up to date with the biosimilars industry?

Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.

SIGN UP FOR OUR NEWSLETTER